Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,765 total articles
Olaplex Holdings, a leading science-driven prestige hair care company listed on NASDAQ as OLPX, announced a definitive agreement for acquisition by Henkel AG & Co. KGaA for $2.06 per share in cash, valuing Olaplex at approximately $1.4 billion, representing a 55% premium over the closing share price. The transaction, expected to close in the second…
Brookfield Wealth Solutions Ltd. announced the filing of its 2025 annual report and audited financial statements for the year ended December 31, 2025, with both the SEC and Canadian securities authorities. The filings are publicly accessible online and hard copies are available to shareholders on request.
Archrock, a Houston-based energy infrastructure company specializing in midstream natural gas compression, announced that CFO Douglas S. Aron plans to retire by the end of 2026 or upon appointment of a successor. The company has engaged an executive search firm to find a replacement. The leadership affirmed confidence in the company's strategy and …
Ascentage Pharma reported a 90% year-over-year increase in product sales and commercial rights revenues for 2025, driven by significant growth in sales of Olverembatinib and the launch of Lisaftoclax in China. The company is advancing multiple ongoing global registrational Phase III clinical trials, including several FDA and EMA cleared studies, wh…
ArrowMark Financial Corp. announced its estimated and unaudited Net Asset Value (NAV) as of February 28, 2026, at $21.18 per share. The firm is a closed-end fund listed on NASDAQ focusing on income through investments primarily in regulatory capital securities of financial institutions. The announcement includes a reminder of associated investment …
Oragenics, Inc., a clinical-stage biotech company focused on brain-targeted therapeutics via intranasal delivery, announced it received an unqualified audit opinion containing a going concern explanatory paragraph for its 2025 financial statements. This indicates substantial doubt about its ability to continue as a going concern, reflecting financi…
XORTX Therapeutics Inc. disclosed a 1-for-5 share consolidation effective March 27, 2026, approved by its board and regulatory bodies, aimed at ensuring compliance with NASDAQ's $1.00 minimum bid price requirement. The company's total outstanding shares will decrease from approximately 6.96 million to 1.39 million, adjusting convertible securities …
Golar LNG Limited has announced the initiation of a formal strategic review process to evaluate alternatives aimed at maximizing shareholder value and accelerating its Floating Liquefied Natural Gas (FLNG) growth pipeline. The company has appointed Goldman Sachs International as its financial advisor to assist with this review, which may explore op…
BlackRock Asset Management Canada, a subsidiary of BlackRock, Inc., announced the final cash distribution for March 2026 of the iShares Premium Money Market ETF (Ticker: CMR). Unitholders as of March 26, 2026, will receive a cash distribution of $0.094 per unit payable on March 31, 2026.
Marex Group plc, a diversified global financial services platform specializing in commodity and financial markets, announced the filing of its annual report on Form 20-F with the SEC for the fiscal year ended December 31, 2025. The comprehensive report includes audited consolidated financial statements and is accessible on the company's website, wi…
Toppoint Holdings provided a 2025 year-end business update showing a 3.2% revenue increase driven by strong growth in import freight and scrap metal transportation, offsetting declines in waste paper revenue. Despite revenue growth, the company reported a net loss due to higher costs, including investments in infrastructure, technology, and public …
Polyrizon Ltd., a Nasdaq-listed pre-clinical-stage biotech company specializing in intranasal hydrogel medical devices, announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. SEC. The report details their development progress in their proprietary Capture and Contain™ hydrogel technology and …
B2Gold Corp. announced positive drilling results from its 2025 exploration program at the Back River Gold District in Nunavut, Canada. The results demonstrate significant resource potential district-wide, including resource upgrades at the Goose Mine’s Llama deposit and extension of high-grade mineralization at the Nuvuyak deposit. The 2025 program…
CNH Industrial announced its 2026 Annual General Meeting to be held on May 8 in Amsterdam. The company published AGM materials online and plans a webcast. The Board proposes a cash dividend of $0.10 per share, pending shareholder approval, with payment expected in late May 2026. CNH Industrial is a global leader in agricultural and construction equ…
Enerpac Tool Group reported a 6% increase in net sales to $155 million for the second quarter of fiscal 2026, driven by 6% organic growth in Industrial Tools & Services (IT&S) product sales and 27% growth at Cortland Biomedical. Operating profit margin was 16.2% with adjusted operating margin at 19.0%. Despite growth in product sales, the service s…
Eldorado Gold Corporation has entered a Memorandum of Understanding with G Mining Services to establish a strategic engineering and construction alliance. This partnership aims to improve project readiness, delivery certainty, and capital efficiency for Eldorado's current and future mining projects, including Perama Hill, Lamaque Complex, Skouries,…
Millicom International Cellular S.A. (Nasdaq: TIGO) convenes its Annual General Meeting (AGM) for May 20, 2026, in Luxembourg. The AGM agenda includes approval of 2025 financials, distribution of a $3 per share annual dividend payable in four installments during 2026-2027, re-election of all eight board members, approval of directors' remuneration,…
FibroBiologics, a clinical-stage biotechnology company, announced a Board-approved 1-for-20 reverse stock split effective March 30, 2026, aimed at regaining compliance with Nasdaq's minimum bid price requirement. The reverse split reduces the number of outstanding shares significantly while maintaining the existing authorized share count and does n…
Glacier Bancorp, Inc. announced a quarterly dividend of $0.33 per share, continuing its track record of 164 consecutive quarterly dividends and 49 increases in the dividend amount. This signals the company's strong financial health and commitment to returning value to shareholders, with dividends payable on April 16, 2026.
Apollo Global Management has priced an offering of $750 million aggregate principal amount of 5.700% Senior Notes due 2036. The proceeds will be used for general corporate purposes, including repaying the $500 million 4.400% Senior Notes due 2026, and related fees. The offering is expected to close on March 30, 2026, and is managed by major financi…
BeyondSpring Inc., a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, announced the filing of its 2025 annual report on Form 10-K with the SEC. The report includes audited consolidated financial statements and details about its pipeline, including the late-stage clinical asset Plinabulin targeting non-small cel…
Dime Community Bancshares, a New York State-chartered trust company with $15 billion in assets and a leading deposit market share on Long Island, announced a quarterly cash dividend of $0.25 per common share payable on April 24, 2026. This continues the company's trend of uninterrupted dividends, highlighting financial stability and shareholder val…
Serina Therapeutics reported full year 2025 financial results, highlighting FDA clearance of IND application and initiation of Phase 1b trial for SER-252 targeting advanced Parkinson's disease. The company also closed a private placement financing up to $30 million, enhancing its financial position to support clinical progress. R&D and operating ex…
Exicure, Inc. disclosed its full-year 2025 financial results, reporting a net loss of $4.9 million, an improvement from $9.7 million in 2024 primarily due to a $6 million gain from early lease termination. The company incurred increased R&D and administrative expenses following its acquisition of GPCR Therapeutics USA Inc. It ended 2025 with $3.7 m…
Emergent BioSolutions announced a $54 million contract award with the U.S. government and $6.6 million in new orders from an international government partner to supply smallpox medical countermeasures CNJ-016® and ACAM2000®. These contracts support biodefense and public health preparedness efforts against smallpox and other biological threats, foll…
